| Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information. |
| |
| Device | DEXCOM G5 MOBILE CONTINUOUS GLUCOSE MONITORING SYSTEM |
| Generic Name | Sensor, glucose, invasive, non-adjunctive |
| Applicant | Dexcom, Inc. 6340 Sequence Dr. San Diego, CA 92121 |
| PMA Number | P120005 |
| Supplement Number | S083 |
| Date Received | 06/27/2019 |
| Decision Date | 11/01/2019 |
| Withdrawal Date | 03/20/2026 |
| Product Code |
PQF |
| Advisory Committee |
Clinical Chemistry |
| Clinical Trials | NCT01514292
|
| Supplement Type | Normal 180 Day Track No User Fee |
| Supplement Reason | Postapproval Study Protocol |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
| Recalls | CDRH Recalls |
Approval Order Statement Approval for updates to the protocol (PTL901895, V004), including addition of the Dexcom G6 CGM. |
|
|